| Multiple Sclerosis |
1 |
1 |
| Spasticity |
0 |
0.99 |
| Pain |
0 |
0.47 |
| Adverse Effects |
0 |
0.38 |
| Anxiety |
0 |
0.28 |
| Sleep |
0 |
0.28 |
| Pain Management |
0 |
0.98 |
| Patient Safety |
0 |
0.2 |
| Health Care Quality, Access, and Evaluation |
0 |
0.19 |
| Insomnia |
0 |
0.19 |
| Anxiety Disorder |
0 |
0.14 |
| Medical Marijuana |
0 |
0.97 |
| Depression |
0 |
0.12 |
| Migraine |
0 |
0.1 |
| Revenue and Practice Management |
0 |
0.1 |
| Aura |
0 |
0.09 |
| Bladder |
0 |
0.09 |
| Clinician Health and Well-Being |
0 |
0.09 |
| Cognition |
0 |
0.09 |
| Dorsum |
0 |
0.09 |
| Hospital |
0 |
0.09 |
| Insurance |
0 |
0.09 |
| Multiple Sclerosis Treatment |
0 |
0.96 |
| Nausea |
0 |
0.09 |
| Sleep Disorders |
0 |
0.09 |
| Smoking |
0 |
0.09 |
| Social Determinants of Health |
0 |
0.09 |
| Tremor |
0 |
0.09 |
| Overactive Bladder |
0 |
0.06 |
| Headache |
0 |
0.04 |
| Medical Life |
0 |
0.04 |
| Tobacco Cessation |
0 |
0.04 |